Depression in atrial fibrillation in the general population

Standard

Depression in atrial fibrillation in the general population. / Schnabel, Renate B; Michal, Matthias; Wilde, Sandra; Wiltink, Jörg; Wild, Philipp S; Sinning, Christoph R; Lubos, Edith; Ojeda, Francisco M; Zeller, Tanja; Munzel, Thomas; Blankenberg, Stefan; Beutel, Manfred E.

in: PLOS ONE, Jahrgang 8, Nr. 12, 2013, S. e79109.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{3ffb0bc0789247aebfb2678ad6f60bce,
title = "Depression in atrial fibrillation in the general population",
abstract = "BACKGROUND: Initial evidence suggests that depressive symptoms are more frequent in patients with atrial fibrillation. Data from the general population are limited.METHODS AND RESULTS: In 10,000 individuals (mean age 56±11 years, 49.4% women) of the population-based Gutenberg Health Study we assessed depression by the Patient Health Questionnaire (PHQ-9) and a history of depression in relation to manifest atrial fibrillation (n = 309 cases). The median (25th/75th percentile) PHQ-9 score of depressive symptoms was 4 (2/6) in atrial fibrillation individuals versus 3 (2/6) individuals without atrial fibrillation, P(X2-Test) = 0.32. Multivariable regression analyses of the severity of depressive symptoms in relation to atrial fibrillation in cardiovascular risk factor adjusted models revealed a relation of PHQ-9 values and atrial fibrillation (odds ratio (OR) 1.04, 95% confidence interval (CI) 1.01-1.08; P = 0.023). The association was stronger for the somatic symptom dimension of depression (OR 1.08, 95% CI 1.02-1.15; P = 0.0085) than for cognitive symptoms (OR 1.05, 95% CI 0.98-1.11; P = 0.15). Results did not change markedly after additional adjustment for heart failure, partnership status or the inflammatory biomarker C-reactive protein. Both, self-reported physical health status, very good/good versus fair/bad, (OR 0.54, 95% CI 0.41-0.70; P<0.001) and mental health status (OR 0.61 (0.46-0.82); P = 0.0012) were associated with atrial fibrillation in multivariable-adjusted models.CONCLUSIONS: In a population-based sample we observed a higher burden of depressive symptoms driven by somatic symptom dimensions in individuals with atrial fibrillation. Depression was associated with a worse perception of physical or mental health status. Whether screening and treatment of depressive symptoms modulates disease progression and outcome needs to be shown.",
keywords = "Adult, Aged, Atrial Fibrillation/complications, C-Reactive Protein/metabolism, Depression/complications, Female, Germany/epidemiology, Heart Failure/pathology, Humans, Male, Middle Aged, Multivariate Analysis, Severity of Illness Index, Surveys and Questionnaires",
author = "Schnabel, {Renate B} and Matthias Michal and Sandra Wilde and J{\"o}rg Wiltink and Wild, {Philipp S} and Sinning, {Christoph R} and Edith Lubos and Ojeda, {Francisco M} and Tanja Zeller and Thomas Munzel and Stefan Blankenberg and Beutel, {Manfred E}",
year = "2013",
doi = "10.1371/journal.pone.0079109",
language = "English",
volume = "8",
pages = "e79109",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

RIS

TY - JOUR

T1 - Depression in atrial fibrillation in the general population

AU - Schnabel, Renate B

AU - Michal, Matthias

AU - Wilde, Sandra

AU - Wiltink, Jörg

AU - Wild, Philipp S

AU - Sinning, Christoph R

AU - Lubos, Edith

AU - Ojeda, Francisco M

AU - Zeller, Tanja

AU - Munzel, Thomas

AU - Blankenberg, Stefan

AU - Beutel, Manfred E

PY - 2013

Y1 - 2013

N2 - BACKGROUND: Initial evidence suggests that depressive symptoms are more frequent in patients with atrial fibrillation. Data from the general population are limited.METHODS AND RESULTS: In 10,000 individuals (mean age 56±11 years, 49.4% women) of the population-based Gutenberg Health Study we assessed depression by the Patient Health Questionnaire (PHQ-9) and a history of depression in relation to manifest atrial fibrillation (n = 309 cases). The median (25th/75th percentile) PHQ-9 score of depressive symptoms was 4 (2/6) in atrial fibrillation individuals versus 3 (2/6) individuals without atrial fibrillation, P(X2-Test) = 0.32. Multivariable regression analyses of the severity of depressive symptoms in relation to atrial fibrillation in cardiovascular risk factor adjusted models revealed a relation of PHQ-9 values and atrial fibrillation (odds ratio (OR) 1.04, 95% confidence interval (CI) 1.01-1.08; P = 0.023). The association was stronger for the somatic symptom dimension of depression (OR 1.08, 95% CI 1.02-1.15; P = 0.0085) than for cognitive symptoms (OR 1.05, 95% CI 0.98-1.11; P = 0.15). Results did not change markedly after additional adjustment for heart failure, partnership status or the inflammatory biomarker C-reactive protein. Both, self-reported physical health status, very good/good versus fair/bad, (OR 0.54, 95% CI 0.41-0.70; P<0.001) and mental health status (OR 0.61 (0.46-0.82); P = 0.0012) were associated with atrial fibrillation in multivariable-adjusted models.CONCLUSIONS: In a population-based sample we observed a higher burden of depressive symptoms driven by somatic symptom dimensions in individuals with atrial fibrillation. Depression was associated with a worse perception of physical or mental health status. Whether screening and treatment of depressive symptoms modulates disease progression and outcome needs to be shown.

AB - BACKGROUND: Initial evidence suggests that depressive symptoms are more frequent in patients with atrial fibrillation. Data from the general population are limited.METHODS AND RESULTS: In 10,000 individuals (mean age 56±11 years, 49.4% women) of the population-based Gutenberg Health Study we assessed depression by the Patient Health Questionnaire (PHQ-9) and a history of depression in relation to manifest atrial fibrillation (n = 309 cases). The median (25th/75th percentile) PHQ-9 score of depressive symptoms was 4 (2/6) in atrial fibrillation individuals versus 3 (2/6) individuals without atrial fibrillation, P(X2-Test) = 0.32. Multivariable regression analyses of the severity of depressive symptoms in relation to atrial fibrillation in cardiovascular risk factor adjusted models revealed a relation of PHQ-9 values and atrial fibrillation (odds ratio (OR) 1.04, 95% confidence interval (CI) 1.01-1.08; P = 0.023). The association was stronger for the somatic symptom dimension of depression (OR 1.08, 95% CI 1.02-1.15; P = 0.0085) than for cognitive symptoms (OR 1.05, 95% CI 0.98-1.11; P = 0.15). Results did not change markedly after additional adjustment for heart failure, partnership status or the inflammatory biomarker C-reactive protein. Both, self-reported physical health status, very good/good versus fair/bad, (OR 0.54, 95% CI 0.41-0.70; P<0.001) and mental health status (OR 0.61 (0.46-0.82); P = 0.0012) were associated with atrial fibrillation in multivariable-adjusted models.CONCLUSIONS: In a population-based sample we observed a higher burden of depressive symptoms driven by somatic symptom dimensions in individuals with atrial fibrillation. Depression was associated with a worse perception of physical or mental health status. Whether screening and treatment of depressive symptoms modulates disease progression and outcome needs to be shown.

KW - Adult

KW - Aged

KW - Atrial Fibrillation/complications

KW - C-Reactive Protein/metabolism

KW - Depression/complications

KW - Female

KW - Germany/epidemiology

KW - Heart Failure/pathology

KW - Humans

KW - Male

KW - Middle Aged

KW - Multivariate Analysis

KW - Severity of Illness Index

KW - Surveys and Questionnaires

U2 - 10.1371/journal.pone.0079109

DO - 10.1371/journal.pone.0079109

M3 - SCORING: Journal article

C2 - 24324579

VL - 8

SP - e79109

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 12

ER -